Scholars Central

Conference abstract

Na,K-ATPase isoform-selective cardiac glycosides: A potential anti-cancer drug?

Authors: Adriana Katz, Cherniavsky-Lev M, Ainbinder E, Tal D, Karlish S J D

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

N a, K-ATPase is present in the membrane of most eukaryotic cells and creates trans-membrane gradients of Na and K ions, which control directly or indirectly essential physiological functions of all animal cells. Regulation of this enzyme and its isoforms is believed to play a key role in various pathological processes, including cancer. The Na+, K+-ATPase consists of two subunits, α and β , in addition to a single membrane-span FXYD regulatory protein. There are four isoforms of α ( α 1-4) and three isoforms of β (β1-3), which are expressed in a tissue-specific fashion. Cardiac glycosides (CG) such as digoxin or ouabain are specific inhibitors of Na,K-ATPase. CG?s display distinct in vitro anti-cancer effects, but the full anti-cancer potential of this drug has not yet been addressed. In order to improve selectivity and affinity of cardiac glycosides for the different α isoforms of the human Na,K-ATPase we synthesized new digoxin derivatives, modified in the sugar moiety. We have investigated the effects of CG?s and the digoxin derivatives on cell growth and survival of different human cancer cell lines. The IC50 values for growth inhibition of human cancer cells in vitro are linearly correlated with the number of binding sites of NaK-ATPase and with the Ki for inhibition of the purified human NaKα1β1 complex. Together, these observations imply that the IC50 values by the different compounds are a consequence of binding to and inhibition of the pump, andquestion the potential of cardiac glycoside as selective anti-cancer drugs

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioequivalence & Bioavailability
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Adriana Katz”
  • BylineArticles whose byline prints “Cherniavsky-Lev M”
  • BylineArticles whose byline prints “Ainbinder E”
  • BylineArticles whose byline prints “Tal D”
  • BylineArticles whose byline prints “Karlish S J D”